Familial Mediterranean Fever
📧 Sign up to get email alerts when something new happens for Familial Mediterranean Fever.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-14FDA Approved: COLCHICINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for colchicine submitted by Par Health USA, LLC. The action pertains to the generic colchicine produ…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Investigation of the Validity, Reliability and Responsiveness of the BETY-BQ in FMF
A clinical trial is evaluating the validity, reliability, and responsiveness of the BETY-BQ in Familial Mediterranean Fever.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. [NA]
A completed clinical trial evaluating Pilates-based exercises in patients with Behçet's disease and familial Mediterranean fever.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic
A completed clinical-trial analysis examining Familial Mediterranean Fever and Behçet disease before and after the COVID-19 pandemic.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Comparison of the Effects of Synchronous and Asynchronous Telerehabilitation in Patients with Juvenile Familial Mediterranean Fever [NA]
A clinical trial update evaluating synchronous versus asynchronous telerehabilitation in juvenile patients with Familial Mediterranean Fever…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of RPH-104 to prevent recurrent fever attacks in adults with colchicine-resistant …
-
FDA approval · 2024-12-12FDA Approved: COLCHICINE — Supplemental Application (Granules Pharmaceutical Inc.)
The FDA approved a supplemental application for Colchicine from Granules Pharmaceutical Inc., updating the approved Colchicine product.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Barriers to Physical Activity in Familial Mediterranean Fever
A clinical trial from Istanbul University is examining barriers to physical activity in Familial Mediterranean Fever, currently not yet recr…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of RPH-104 for resolution and prevention of recurring attacks in adults with Famil…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System
A registry-style update on a pediatric gait study using a smart insole to evaluate rheumatic diseases, focusing on juvenile idiopathic arthr…
-
FDA approval · 2024-10-11FDA Approved: COLCHICINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Colchicine from Camber Pharmaceuticals, Inc., resulting in an approved change to an existing…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Hematological Indices in Pediatric Diagnosed With Familial Mediterranean Fever
A pediatric study is planned to evaluate hematological indices in children diagnosed with Familial Mediterranean Fever, with the trial curre…
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
This clinical trial update describes the characterization of a functional screening test for Familial Mediterranean Fever (MEFV gene mutatio…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: "Galectin-3 as a Marker of Subclinical Inflammation in FMF"
A completed clinical trial evaluating galectin-3 as a marker of subclinical inflammation in familial Mediterranean fever.
-
FDA approval · 2024-05-16FDA Approved: MITIGARE — Supplemental Application (Hikma Specialty USA Inc.)
FDA approved a supplemental application for Mitigare (colchicine) submitted by Hikma Specialty USA Inc. The action updates the product label…
-
FDA approval · 2024-04-29FDA Approved: COLCHICINE — Original Application (Granules Pharmaceutical Inc.)
FDA approved an Original Application for a generic colchicine product by Granules Pharmaceutical Inc., establishing a generic option for col…
-
FDA approval · 2024-04-29FDA Approved: COLCHICINE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals’ generic colchicine under an original ANDA, authorizing its marketing as a generic product.
-
FDA approval · 2024-04-29FDA Approved: COLCHICINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for a generic colchicine product.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever [Phase 3]
Phase 3 trial update for Kineret (anakinra) in adult patients with colchicine-resistant familial Mediterranean fever has been completed.
-
FDA approval · 2023-06-16FDA Approved: LODOCO — Original Application (AGEPHA Pharma USA, LLC)
FDA approved LODOCO (colchicine tablets 0.5 mg) under an original NDA from AGEPHA Pharma USA, LLC.
-
FDA approval · 2022-03-10FDA Approved: COLCHICINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for colchicine from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), providing a generic version of…
-
FDA approval · 2022-01-06FDA Approved: COLCHICINE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic colchicine product. This approval recognizes a generic colchi…
-
FDA approval · 2021-08-13FDA Approved: COLCHICINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for colchicine, authorizing a generic version of the drug.
-
FDA approval · 2021-08-12FDA Approved: COLCHICINE — Original Application (Par Health USA, LLC)
FDA approved the original application for colchicine (generic) from Par Health USA, LLC.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Tocilizumab for the Treatment of Familial Mediterranean Fever [Phase 2]
Phase 2 clinical trial evaluating tocilizumab for Familial Mediterranean Fever has completed.